Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR) : correlation between genotype and phenotype

To assess better the link between congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis (CF), we compared sweat chloride values, analysis of the CFTR intron 8 poly(T) tract length and analysis of 10 exons in a population of 38 patients with CBAVD. The data indicate that this p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human genetics 1996, Vol.97 (1), p.7-10
Hauptverfasser: DUMUR, V, GERVAIS, R, RIGOT, J.-M, DELOMEL-VINNER, E, DECAESTECKER, B, LAFITTE, J.-J, ROUSSEL, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10
container_issue 1
container_start_page 7
container_title Human genetics
container_volume 97
creator DUMUR, V
GERVAIS, R
RIGOT, J.-M
DELOMEL-VINNER, E
DECAESTECKER, B
LAFITTE, J.-J
ROUSSEL, P
description To assess better the link between congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis (CF), we compared sweat chloride values, analysis of the CFTR intron 8 poly(T) tract length and analysis of 10 exons in a population of 38 patients with CBAVD. The data indicate that this population can be divided into three groups of patients. In the first group of 15 patients with abnormal sweat chloride (> 60 mmol/l), the frequency of CF mutations is high. In the second group of 18 patients with equivocal sweat chloride (between 40 and 60 mmol/l), the frequency of the 5T variant is high; 6 patients have a delta F508 mutation and a 5T variant and 1 patient is homozygous for the 5T variant; a 5T variant has been detected in 3 other patients, and a delta F508 mutation in another patient. A third group of 5 patients is probably not related to CF: these patients have other congenital abnormalities of the urogenital tract, low chloride values (< 40 mmol/l) and apparently no abnormality of the CF gene.
doi_str_mv 10.1007/BF00218824
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77965085</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17089813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342t-4aad52e3feda5a3f57c3fcf87e1f5e0765b439b7338114a4f7f3127d91e254d43</originalsourceid><addsrcrecordid>eNqFkU9PGzEQxa2qKA1pL71X8qFCBWmp_8a73CAlgIRUCdFeV17vOBjtroPtUOWb8HFrYBWOnMae-fmN_B5CXyk5poSon2dLQhgtSyY-oCkVnBWUEf4RTQkXpJgrqj6h_RjvCaGyYnKCJqWUis3FFD0t_LCCwSXd4cZ1OkHIJ91EGAxgb3G6A_yoI27BQoAh4h-Ls9O_vw6xHlpstjE5g61rgo8u4hT0EHvom1wBB1htsqIP-c3y9uYQn2DjQ4Dcc37ADaR_AAPO633aruFFcX033j6jPau7CF_GOkN_lue3i8vi-vfF1eL0ujBcsFQIrVvJgFtotdTcSmW4NbZUQK0EouayEbxqFOclpUILqyynTLUVBSZFK_gMHbzqroN_2EBMde-iga7LP_CbWCtVzSUp5bsgVaSsSsozePQKmmxKDGDrdXC9Dtuakvo5r_otrwx_G1U3TQ_tDh0DyvPv41xHozubjTUu7jCW46xIxf8D1hWdog</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17089813</pqid></control><display><type>article</type><title>Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR) : correlation between genotype and phenotype</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>DUMUR, V ; GERVAIS, R ; RIGOT, J.-M ; DELOMEL-VINNER, E ; DECAESTECKER, B ; LAFITTE, J.-J ; ROUSSEL, P</creator><creatorcontrib>DUMUR, V ; GERVAIS, R ; RIGOT, J.-M ; DELOMEL-VINNER, E ; DECAESTECKER, B ; LAFITTE, J.-J ; ROUSSEL, P</creatorcontrib><description>To assess better the link between congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis (CF), we compared sweat chloride values, analysis of the CFTR intron 8 poly(T) tract length and analysis of 10 exons in a population of 38 patients with CBAVD. The data indicate that this population can be divided into three groups of patients. In the first group of 15 patients with abnormal sweat chloride (&gt; 60 mmol/l), the frequency of CF mutations is high. In the second group of 18 patients with equivocal sweat chloride (between 40 and 60 mmol/l), the frequency of the 5T variant is high; 6 patients have a delta F508 mutation and a 5T variant and 1 patient is homozygous for the 5T variant; a 5T variant has been detected in 3 other patients, and a delta F508 mutation in another patient. A third group of 5 patients is probably not related to CF: these patients have other congenital abnormalities of the urogenital tract, low chloride values (&lt; 40 mmol/l) and apparently no abnormality of the CF gene.</description><identifier>ISSN: 0340-6717</identifier><identifier>EISSN: 1432-1203</identifier><identifier>DOI: 10.1007/BF00218824</identifier><identifier>PMID: 8557264</identifier><identifier>CODEN: HUGEDQ</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adult ; Biological and medical sciences ; Chlorides - analysis ; Congenital Abnormalities - genetics ; Cystic Fibrosis Transmembrane Conductance Regulator - deficiency ; Cystic Fibrosis Transmembrane Conductance Regulator - genetics ; Exons ; Genetic Variation ; Genotype ; Gynecology. Andrology. Obstetrics ; Humans ; Introns ; Male ; Male genital diseases ; Medical sciences ; Middle Aged ; Mutation ; Non tumoral diseases ; Phenotype ; Sweat - chemistry ; Vas Deferens - abnormalities</subject><ispartof>Human genetics, 1996, Vol.97 (1), p.7-10</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c342t-4aad52e3feda5a3f57c3fcf87e1f5e0765b439b7338114a4f7f3127d91e254d43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2925909$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8557264$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DUMUR, V</creatorcontrib><creatorcontrib>GERVAIS, R</creatorcontrib><creatorcontrib>RIGOT, J.-M</creatorcontrib><creatorcontrib>DELOMEL-VINNER, E</creatorcontrib><creatorcontrib>DECAESTECKER, B</creatorcontrib><creatorcontrib>LAFITTE, J.-J</creatorcontrib><creatorcontrib>ROUSSEL, P</creatorcontrib><title>Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR) : correlation between genotype and phenotype</title><title>Human genetics</title><addtitle>Hum Genet</addtitle><description>To assess better the link between congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis (CF), we compared sweat chloride values, analysis of the CFTR intron 8 poly(T) tract length and analysis of 10 exons in a population of 38 patients with CBAVD. The data indicate that this population can be divided into three groups of patients. In the first group of 15 patients with abnormal sweat chloride (&gt; 60 mmol/l), the frequency of CF mutations is high. In the second group of 18 patients with equivocal sweat chloride (between 40 and 60 mmol/l), the frequency of the 5T variant is high; 6 patients have a delta F508 mutation and a 5T variant and 1 patient is homozygous for the 5T variant; a 5T variant has been detected in 3 other patients, and a delta F508 mutation in another patient. A third group of 5 patients is probably not related to CF: these patients have other congenital abnormalities of the urogenital tract, low chloride values (&lt; 40 mmol/l) and apparently no abnormality of the CF gene.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Chlorides - analysis</subject><subject>Congenital Abnormalities - genetics</subject><subject>Cystic Fibrosis Transmembrane Conductance Regulator - deficiency</subject><subject>Cystic Fibrosis Transmembrane Conductance Regulator - genetics</subject><subject>Exons</subject><subject>Genetic Variation</subject><subject>Genotype</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Introns</subject><subject>Male</subject><subject>Male genital diseases</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Non tumoral diseases</subject><subject>Phenotype</subject><subject>Sweat - chemistry</subject><subject>Vas Deferens - abnormalities</subject><issn>0340-6717</issn><issn>1432-1203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9PGzEQxa2qKA1pL71X8qFCBWmp_8a73CAlgIRUCdFeV17vOBjtroPtUOWb8HFrYBWOnMae-fmN_B5CXyk5poSon2dLQhgtSyY-oCkVnBWUEf4RTQkXpJgrqj6h_RjvCaGyYnKCJqWUis3FFD0t_LCCwSXd4cZ1OkHIJ91EGAxgb3G6A_yoI27BQoAh4h-Ls9O_vw6xHlpstjE5g61rgo8u4hT0EHvom1wBB1htsqIP-c3y9uYQn2DjQ4Dcc37ADaR_AAPO633aruFFcX033j6jPau7CF_GOkN_lue3i8vi-vfF1eL0ujBcsFQIrVvJgFtotdTcSmW4NbZUQK0EouayEbxqFOclpUILqyynTLUVBSZFK_gMHbzqroN_2EBMde-iga7LP_CbWCtVzSUp5bsgVaSsSsozePQKmmxKDGDrdXC9Dtuakvo5r_otrwx_G1U3TQ_tDh0DyvPv41xHozubjTUu7jCW46xIxf8D1hWdog</recordid><startdate>1996</startdate><enddate>1996</enddate><creator>DUMUR, V</creator><creator>GERVAIS, R</creator><creator>RIGOT, J.-M</creator><creator>DELOMEL-VINNER, E</creator><creator>DECAESTECKER, B</creator><creator>LAFITTE, J.-J</creator><creator>ROUSSEL, P</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>1996</creationdate><title>Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR) : correlation between genotype and phenotype</title><author>DUMUR, V ; GERVAIS, R ; RIGOT, J.-M ; DELOMEL-VINNER, E ; DECAESTECKER, B ; LAFITTE, J.-J ; ROUSSEL, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342t-4aad52e3feda5a3f57c3fcf87e1f5e0765b439b7338114a4f7f3127d91e254d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Chlorides - analysis</topic><topic>Congenital Abnormalities - genetics</topic><topic>Cystic Fibrosis Transmembrane Conductance Regulator - deficiency</topic><topic>Cystic Fibrosis Transmembrane Conductance Regulator - genetics</topic><topic>Exons</topic><topic>Genetic Variation</topic><topic>Genotype</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Introns</topic><topic>Male</topic><topic>Male genital diseases</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Non tumoral diseases</topic><topic>Phenotype</topic><topic>Sweat - chemistry</topic><topic>Vas Deferens - abnormalities</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DUMUR, V</creatorcontrib><creatorcontrib>GERVAIS, R</creatorcontrib><creatorcontrib>RIGOT, J.-M</creatorcontrib><creatorcontrib>DELOMEL-VINNER, E</creatorcontrib><creatorcontrib>DECAESTECKER, B</creatorcontrib><creatorcontrib>LAFITTE, J.-J</creatorcontrib><creatorcontrib>ROUSSEL, P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Human genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DUMUR, V</au><au>GERVAIS, R</au><au>RIGOT, J.-M</au><au>DELOMEL-VINNER, E</au><au>DECAESTECKER, B</au><au>LAFITTE, J.-J</au><au>ROUSSEL, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR) : correlation between genotype and phenotype</atitle><jtitle>Human genetics</jtitle><addtitle>Hum Genet</addtitle><date>1996</date><risdate>1996</risdate><volume>97</volume><issue>1</issue><spage>7</spage><epage>10</epage><pages>7-10</pages><issn>0340-6717</issn><eissn>1432-1203</eissn><coden>HUGEDQ</coden><abstract>To assess better the link between congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis (CF), we compared sweat chloride values, analysis of the CFTR intron 8 poly(T) tract length and analysis of 10 exons in a population of 38 patients with CBAVD. The data indicate that this population can be divided into three groups of patients. In the first group of 15 patients with abnormal sweat chloride (&gt; 60 mmol/l), the frequency of CF mutations is high. In the second group of 18 patients with equivocal sweat chloride (between 40 and 60 mmol/l), the frequency of the 5T variant is high; 6 patients have a delta F508 mutation and a 5T variant and 1 patient is homozygous for the 5T variant; a 5T variant has been detected in 3 other patients, and a delta F508 mutation in another patient. A third group of 5 patients is probably not related to CF: these patients have other congenital abnormalities of the urogenital tract, low chloride values (&lt; 40 mmol/l) and apparently no abnormality of the CF gene.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><cop>New York, NY</cop><pub>Springer</pub><pmid>8557264</pmid><doi>10.1007/BF00218824</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0340-6717
ispartof Human genetics, 1996, Vol.97 (1), p.7-10
issn 0340-6717
1432-1203
language eng
recordid cdi_proquest_miscellaneous_77965085
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adult
Biological and medical sciences
Chlorides - analysis
Congenital Abnormalities - genetics
Cystic Fibrosis Transmembrane Conductance Regulator - deficiency
Cystic Fibrosis Transmembrane Conductance Regulator - genetics
Exons
Genetic Variation
Genotype
Gynecology. Andrology. Obstetrics
Humans
Introns
Male
Male genital diseases
Medical sciences
Middle Aged
Mutation
Non tumoral diseases
Phenotype
Sweat - chemistry
Vas Deferens - abnormalities
title Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR) : correlation between genotype and phenotype
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T15%3A29%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Congenital%20bilateral%20absence%20of%20the%20vas%20deferens%20(CBAVD)%20and%20cystic%20fibrosis%20transmembrane%20regulator%20(CFTR)%20:%20correlation%20between%20genotype%20and%20phenotype&rft.jtitle=Human%20genetics&rft.au=DUMUR,%20V&rft.date=1996&rft.volume=97&rft.issue=1&rft.spage=7&rft.epage=10&rft.pages=7-10&rft.issn=0340-6717&rft.eissn=1432-1203&rft.coden=HUGEDQ&rft_id=info:doi/10.1007/BF00218824&rft_dat=%3Cproquest_cross%3E17089813%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17089813&rft_id=info:pmid/8557264&rfr_iscdi=true